These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22153886)

  • 1. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
    Lake J; Mak V; Møller H; Davies EA
    Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.
    Pollock AM; Benster R; Vickers N
    J Public Health Med; 1995 Dec; 17(4):419-28. PubMed ID: 8639341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.
    Nennecke AL; Hentschel S; Reintjes R
    Acta Oncol; 2009; 48(1):34-43. PubMed ID: 18607873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers?
    McCarthy M; Datta P; Khachatryan A; Coleman MP; Rachet B
    J Epidemiol Community Health; 2008 Jul; 62(7):650-4. PubMed ID: 18559449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England.
    Davies E; Mak V; Ferguson J; Conaty S; Møller H
    J Public Health (Oxf); 2008 Sep; 30(3):305-12. PubMed ID: 18567570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only.
    Brenner H; Holleczek B
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2480-6. PubMed ID: 21960691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.
    Holleczek B; Brenner H
    Eur J Cancer; 2012 Apr; 48(6):797-804. PubMed ID: 21703847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported cancer spending in relation to population characteristics, disease burden and service activity for primary care trusts in South East England.
    Okello C; Møller H; Davies EA
    J Public Health (Oxf); 2011 Sep; 33(3):445-52. PubMed ID: 21051461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.
    Robinson D; Sankila R; Hakulinen T; Møller H
    Eur J Cancer; 2007 Mar; 43(5):909-13. PubMed ID: 17300929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
    Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
    Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer survival in Kentucky and health insurance coverage.
    McDavid K; Tucker TC; Sloggett A; Coleman MP
    Arch Intern Med; 2003 Oct; 163(18):2135-44. PubMed ID: 14557210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel times to health care and survival from cancers in Northern England.
    Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D
    Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage at diagnosis and early mortality from cancer in England.
    McPhail S; Johnson S; Greenberg D; Peake M; Rous B
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study.
    Dregan A; Moller H; Murray-Thomas T; Gulliford MC
    Cancer Epidemiol; 2012 Oct; 36(5):425-9. PubMed ID: 22727737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 20-year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987-2006.
    Olaleye O; Moorthy R; Lyne O; Black M; Mitchell D; Wiseberg J
    Clin Otolaryngol; 2011 Aug; 36(4):325-35. PubMed ID: 21696555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.